Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer.

@article{Oratz2011PhysicianSO,
  title={Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer.},
  author={Ruth Oratz and Benjamin Youngho Kim and Calvin Y. Chao and Stanley M Skrzypczak and Caron Ory and Roberto Bugarini and Michael F. Broder},
  journal={Journal of oncology practice},
  year={2011},
  volume={7 2},
  pages={94-9}
}
PURPOSE To survey the effect of the 21-gene recurrence score (RS) assay results on adjuvant treatment recommendations for patients with lymph node-positive (N+), estrogen receptor-positive (ER+) breast cancer. METHODS Medical oncologists who ordered the 21-gene RS assay were invited to complete a survey regarding their most recent patient with N+/ER+ breast cancer. We obtained responses from 160 (16%) of the 1,017 medical oncologists. RESULTS Most of the respondents were in community (71… CONTINUE READING
26 Citations
30 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 30 references

cancer patients

  • S Paik, G Tang, D Fumagalli
  • BREAST
  • 2009

Similar Papers

Loading similar papers…